Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F3RXY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $59,558
Award facts
- Contract value 100% obligated
- $59,557.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $59,557.92 delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of Dupixent 300 mg/2 mL pen injections. This competitive award, with a firm fixed price structure and no set-aside designation, is scheduled for completion by December 19, 2025, and will be fulfilled from the vendor's operations in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026 that supports comprehensive pharmaceutical procurement for military and federal healthcare systems globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical supply vendor specializing in brand-name and generic medications, vaccines, and specialized healthcare commodities. The company's extensive portfolio of DLA contract awards demonstrates its capability to meet federal procurement requirements across multiple therapeutic domains. This particular delivery order for Dupixent, a biologic treatment commonly used for atopic dermatitis and other conditions, represents one of numerous competitive awards the vendor maintains through the DLA Medical Supply Chain, positioning it as a key supplier for Defense Health Agency and broader military healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F3RXY?
SPE2DR26F3RXY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 18, 2025.
How much is contract SPE2DR26F3RXY worth?
The government has obligated $59,558 on SPE2DR26F3RXY.
Is contract SPE2DR26F3RXY an order under another contract?
Yes. SPE2DR26F3RXY is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3RXY competed?
The extent of competition for SPE2DR26F3RXY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award